EASL Podcasts
The EASL Podcast collection brings together Talk Liver to Me, EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues. Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology — anytime, anywhere.
Episodes
Talk Liver To Me - Africa’s Liver Crisis: Why Is No One Talking About It?
Liver disease represents a major and under-recognised public health challenge across Africa, driven by a complex interplay of viral hepatitis, rising metabolic dysfunction-associated steatotic liver disease, and a high burden of hepatocellular carcinoma (HCC). Despite this, awareness, surveillance, and access to care remain limited. In this podcast, we explore the evolving epidemiology of liver di
EASL DeepDive: Utility and challenges of genetic testing in PFIC
This webinar explores the role of genetic testing in diagnosing Progressive Familial Intrahepatic Cholestasis (PFIC). Attendees will review key test types, understand the principles behind modern genomic technologies, and learn how to position these tests in the diagnostic approach of a person with a suspicion of PFIC and how to navigate common challenges in interpreting genetic results. The sessi
Talk Liver To Me - What are the Dos and Don'ts in Acute Liver Failure?
Acute liver failure (ALF) is a rare but life-threatening condition requiring rapid recognition and decisive management. Early decisions around investigation, escalation, and referral can significantly impact outcomes. Despite advances in care, variation in practice and avoidable pitfalls remain common. In this podcast, we take a practical, case-based approach to the key “dos and don’ts” in ALF man
Talk Liver To Me - Endohepatology: Added value or added complexity?
Endohepatology is emerging as a novel approach to liver disease assessment, with the potential to combine EUS-guided liver biopsy, portal pressure measurement, and variceal evaluation within a single session. This “one-stop shop” model could streamline diagnostic pathways and enable integrated, real-time clinical decision-making. However, this innovation comes at a time when hepatology is moving i
Talk Liver To Me - What nobody tells you about starting a research group
Early-career researchers and clinician-scientists play a central role in advancing hepatology research and innovation, yet the transition to independence often comes with challenges that extend beyond scientific expertise. Building a research programme, leading teams, securing funding, and developing a sustainable academic career require skills that are rarely addressed during formal training. In
Talk Liver To Me - Global Updates on Hepatitis E: How Should We Manage Acute and Chronic Infection?
Hepatitis E is a globally prevalent infection with diverse clinical manifestations, ranging from self-limiting acute hepatitis to chronic infection in immunosuppressed patients. Its presentation and epidemiology vary significantly between regions, influencing diagnostic and management strategies. Despite increasing recognition, uncertainty remains around who to test, when to treat, and how to mana
Talk Liver To Me - MASLD and HFpEF: Do We Need a Shared Treatment Strategy?
Metabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure with preserved ejection fraction (HFpEF) are increasingly recognised as manifestations of a shared cardiometabolic disorder. Driven by overlapping risk factors such as obesity and insulin resistance, these conditions frequently coexist and may interact through liver–heart crosstalk. Despite this, they are typically
A joint EASL-ERN RARE-LIVER DeepDive – Wilson’s disease: a 2026 update
The following objectives will be addressed in this EASL Deep Dive episode:Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver copper assessmentsBe able to establish a diagnostic approach to Wilson’s disease, integrating clinical, laboratory, genetic and imaging toolsHave a good understanding of the different
Talk Liver To Me - Chasing the perfect SLD preclinical model
Steatotic liver disease (SLD) research relies heavily on preclinical models, yet no single model can fully capture the complexity of human disease. In this episode, we explore the new EASL position paper on preclinical SLD models. From MASLD and MetALD to organoids and precision-cut liver slices, we discuss the strengths, limitations, and translational relevance of today's most widely used mo
Talk Liver To Me - Haemochromatosis in 2026: Who Needs Testing and Who Needs Treatment?
Haemochromatosis remains one of the most common inherited metabolic disorders, yet it is frequently underdiagnosed and inconsistently managed in clinical practice. With widespread use of iron studies and genetic testing, clinicians are increasingly faced with questions around interpretation, penetrance, and clinical significance. In this podcast, we explore current challenges in diagnosis and mana
Talk Liver To Me - Liver Transplantation: Rise of the machines
In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore the accelerating field of machine perfusion, clarifying different approaches and reviewing the evidence supporting their role in organ assessment, optimisation, and DCD utilisation.Host: Sarwa
Talk Liver To Me - Spontaneous Bacterial Peritonitis: Time to Rethink the Rules?
Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices.In this episode, we review current evidence on primary and secondary prophylaxis, resistance patterns, albumin use, and treatment strategies. How should clinicians balance prevention with antimicrobial stewardship? And whe
EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA)
In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma.Learning ObjectivesTo identify patients at risk for eCCA, and review the current tools and strategies for its surveillance, diagnosis, staging, and classificationTo define the o
Talk Liver To Me - World Liver Day: Making Lifestyle Change Possible
This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to start and sustain, and why small, achievable steps can still make a meaningful difference. Host: Cyrielle Caussy Speakers: Kate Hallsworth and Manuel Romero-Gómez This episode is also avai
EASL DeepDive: Key Changes in the New EASL HBV Guidelines
In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025.Learning objectivesUnderstand the updated EASL recommendations for initiating and discontinuing antiviral therapy in chronic hepatitis B, including key differences with other HBV guideli
EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025.Learning objectivesSelect induction and maintenance treatment strategies aimed at achieving complete biochemical responseRecognise and manage disease flares, treatment intolerance, and suboptim
EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies
Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult.In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the ri
Talk Liver To Me - Baveno VIII: The takeaways you shouldn’t miss
In this episode our speakers share their immediate impressions and break down the key highlights shaping the management of portal hypertension and advanced liver disease. What has truly changed in practice? Where was consensus reached and where do controversies remain?Tune in for a clear, practical overview of what you need to know from Baveno VIII.Host: Thomas MarjotSpeakers: Mattias Mandorfer a
Talk Liver To Me - Updated BCLC Guidelines for HCC: Protocolised or Patient-Centred Care?
This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world examples of when the algorithm helps and when clinical practice diverges.Host: Mattias MandorferSpeakers: Marco Sanduzzi, Lorenza RimassaThis episode is a
Talk Liver To Me - When Cure isn’t the only goal: Palliative Care in Advanced Liver Disease
As deaths from advanced chronic liver disease rise, many patients never receive timely palliative care.In this episode, we explore why early, holistic support is essential in advanced liver disease and HCC, and unpack key recommendations from the new EASL Position Paper to help reduce suffering and improve quality of life.Host: Debbie Shawcross Speakers: Patrizia-Künzler-Heule, Sumita Verma This
Talk Liver To Me - MetALD in Practice: Does it Change How We Treat Patients?
This episode explores whether MetALD is a meaningful clinical entity or an unnecessary complication. Experts discuss the overlap between metabolic dysfunction and alcohol use, the challenges of applying the MetALD definition in practice, and its impact on classification, guidelines, drug development, and patient care. Host: Thomas Marjot Speakers: Mary Rinella , Aleksander Krag This episode is
Talk Liver To Me - From imposter syndrome to influence: Women shaping hepatology
EASL’s Secretary General and Vice Secretary General share an open conversation on the challenges and opportunities for women in hepatology. The episode explores the role of mentorship across career stages and reflects on the journey toward EASL’s first female Secretary General, offering insights on leadership and change in the field.Host: Maja ThieleSpeakers: Debbie Shawcross, Ana LleoThis episode
Talk Liver To Me - Hepatology Ward Rounds: East Meets West
In collaboration with the Indian National Association for the Study of the Liver (INASL), hepatologists from South Asia and North America/Europe take listeners inside their liver wards to explore how regional context shapes acute liver care. From admission patterns to alcohol use, infections, DILI, nutrition, and access to transplant, the episode highlights key differences and opportunities for sh
EASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBC
This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC).Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways.Moderator: David JonesSpeakers: Marco Carbone, Bettina Hansen, and Ana L
EASL Studio Podcast: What Can Be Done to Safeguard Young Adults from SLD?
How can we protect young adults from steatotic liver disease (SLD)? This episode explores the burden of MASLD, MetALD, and ALD in Europe, the synergistic effects of alcohol and metabolic risk factors, and why the younger population is especially vulnerable. Experts also examine the disparities in risk factors and the role of clinics and policymakers in prevention.Moderator: Shira Zelber SagiSpeake
EASL Studio Podcast: Decoding AASLD The Liver Meeting: Trends Shaping Hepatology
What were the key takeaways from this year’s AASLD The Liver Meeting? In this episode, experts unpack the most impactful studies, clinical insights, and emerging trends shaping the future of hepatology. From liver cancer breakthroughs to MASLD, ALD, and beyond.Moderator: Debbie ShawcrossSpeakers: Saul Karpen, Allison Kwong, Mazen NoureddinAll EASL Studio Podcasts are available on EASL Campus.Click
EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance
For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial resistance.Moderator: Debbie ShawcrossSpeakers: Rajiv Jalan, Vishal Patel, Jonel TrebickaAll EASL Studio Podcasts are available on EASL Campus.Click here to see all EAS
EASL Studio Podcast: Behind the Decision: How Can You Maximize Your Chances of Publication in JHEP Reports?
Ever wondered what happens to your manuscript after submission? In this episode, the JHEP Reports editorial team takes you behind the scenes: from first triage to reviewer selection, smart moves vs. red flags, and how final decisions are made. The discussion also explores the potential, limitations, and ethical pitfalls.Moderator: Mattias Mandorfer Speakers: Tobias Böttler, Virginia Hernández-Gea,
EASL Studio Podcast: Are we finally entering an era of effective treatment for PSC?
After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode, experts review emerging data and explore whether we’re approaching a new era of effective treatment. How should clinicians assess these therapies, and could they shift the current management of PSC?Moderator: Debbie ShawcrossSpeakers: Cynthia Levy, Stephen Rossi, M
EASL Studio Podcast: Does it really matter whether we call it ACLF or acute decompensation?
This episode questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on the specifics of organ failure and reversibility is more useful. Experts debate the real-world utility of prognostic scores, the clarity (or confusion) created by multiple definitions, and whether the ACLF concept drives urgency, facilitates transplant access, or
EASL Studio Podcast: The Clinical Blind Spot: Are We Neglecting Alcohol?
This EASL Studio explores the discrepancy between the huge burden of patients hospitalised with, and dying from, alcohol-related liver disease (ALD) or MetALD, versus the same disease’s near non-existence from population data. The panel will discuss whether current classification systems (heavily favoring metabolic causes) misrepresent the true burden of ALD and MetALD, and what clinicians can do
EASL Studio Podcast: Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025?
What do we call it when someone with high-risk practices becomes viraemic again after treatment? In this episode, experts discuss the challenges of managing Hepatitis C in people who inject drugs (PWID) and other high-risk groups. Topics include SVR confirmation rates, DAA prescribing practices, acute vs. chronic infection, and real-world reinfection data. Are traditional labels still meaningful o
EASL Studio Podcast: What Matters Most? The questions every hepatologist should ask their patients
In hepatology, effective care goes beyond diagnostics and treatment. This episode explores the crucial questions hepatologists should ask to truly understand their patients’ needs, values, and priorities. By focusing on communication and patient-centred care, our experts highlight how listening carefully can improve adherence, enhance quality of life, and ultimately lead to better outcomes.Moderat
EASL DeepDive: Diagnosis, non-invasive screening and risk stratification of MASLD cases
This first session in a two-part EASL DeepDive series on the 2024 EASL-EASD-EASO MASLD Clinical Practice Guidelines will provide a detailed examination of the recommendations concerning diagnosis, non-invasive assessment, and risk stratification, with a view to supporting evidence-based clinical practice.Learning objectivesHave a good understanding of the concept/definition of MASLD within the fra
EASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New?
This episode addresses key challenges in vascular complications of liver disease, including the management of portal vein thrombosis (PVT) in patients with and without cirrhosis. Experts will explore controversies surrounding long-term anticoagulation therapy and discuss insights from the CIRROXABAN paper. Additionally, the episode will shed light on the management of splanchnic artery aneurysms,
EASL DeepDive: MASLD Cirrhosis: Addressing unmet needs and defining valuable endpoints
In this new edition of the EASL DeepDive, expert faculty guide participants through a focused and forward-looking discussion on key aspects of advanced MASLD, setting the stage for a deeper understanding of evolving clinical challenges and opportunities.This EASL DeepDive webinar is supported by Boehringer Ingelheim. Boehringer Ingelheim has had no input into the content of this EASL DeepDive.Lear
EASL Studio Podcast: Steatotic Liver Disease Unpacked: Targeting Dynamic Risks
This EASL Studio episode explores state-of-the-art practices in diagnosing steatotic liver disease and stratifying patients effectively for targeted treatment in 2025. Focusing on integrating cardiometabolic risk profiling and dynamic alcohol consumption assessment, the discussion will discuss contemporary methods, frequency, and practical implementation in clinical settings to enhance precision m
EASL Studio Podcast: Artificial Intelligence: Is This the Beginning of the End of the Medical Profession as We Know It?
Listen to this EASL Studio episode to explore how artificial intelligence (AI) is transforming healthcare. Discuss its potential to revolutionise medical practice, its limitations, and whether it poses a threat or an opportunity for the future of the medical profession.Moderator: Ahmed Elsharkawy Faculty: Jakob Kather, Sabela Lens, Ashley Spann Related episodes:EASL Studio at EASL Congress 2024 –
EASL Studio Podcast: Rethinking Hepatitis B: Discussions with Patients – Adapting to Expanding Treatment Guidelines
With the release of the new HBV guidelines, treatment eligibility broadens. This EASL Studio explores how to communicate these changes, support shared decision-making, ensure adherence, and engage patients in ongoing care and clinical trials.Moderator: Ahmed Elsharkawy Faculty: Markus Cornberg, Sital Shah, Thomas Tu, Su WangThis EASL Studio is supported by Aligos Therapeutics, GSK and Gilead Scien
EASL Studio Podcast: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical Practice
Listen to this EASL Studio episode for insights on the new MASLD guidelines and their practical application. Hear from experts on navigating the nomenclature change, implementing guidelines in clinical workflows, and fostering behavioral change to improve patient outcomes across the care team.Moderator: Sven Francque Faculty: Marta Cervera, Elena George, Shelley KeatingThis programme is part of th
EASL Studio Podcast: Landmark studies at EASL Congress 2025
Listen to this episode for a curated overview of landmark studies and breakthrough data presented at EASL Congress 2025, with expert insights on their clinical relevance and impact on the future of hepatology.Moderator: Thomas Berg Faculty: Hannes Hagström, Verena Keitel, Raj MookerjeeAll EASL Studio Podcasts are available on EASL Campus.Click here to see all EASL Video Podcasts on Apple Podcasts.
EASL Studio Podcast: Screening strategies for liver fibrosis
Most liver diseases are diagnosed when it’s already too late. This episode explores the pros and cons of early screening, the gaps in current strategies, and how projects like LIVERAiM are aiming to change the game.Moderator: Ahmed ElsharkawyFaculty: Pere Ginès, Ian Rowe, Maja ThieleAll EASL Studio Podcasts are available on EASL Campus.Click here to see all EASL Video Podcasts on Apple Podcasts.
EASL Studio Podcast: Beyond the myths: Alcohol harm and policy action
This EASL Studio episode cuts through the noise to explore alcohol’s true impact on health and society, spotlighting patient stories, public misconceptions, and bold policy solutions from across Europe.Moderator: David Barret (Internal Communications and Multimedia Manager, WHO Regional Office for Europe)Faculty: Carina Ferreira-Borges (Regional Advisor for Alcohol, Illicit drugs and Prison health
EASL/CIRSE Studio Podcast: Interventional radiology in hepatology: Building bridges to optimise care
What happens when hepatologists and interventional radiologists join forces? This episode discusses the power of collaboration – shared guidelines, joint training, and multidisciplinary care – to improve outcomes in complex liver disease.Moderator: Sven FrancqueFaculty: Irene Bargellini, Virginia Hernández-Gea, Max SeidenstickerAll EASL Studio Podcasts are available on EASL Campus.Click here to se
EASL DeepDive: Key for TIPS Success: Identifying Suitable Candidates and Risk Control
In this fifth edition of the EASL DeepDive, join Christophe Bureau, Virginia Hernandez-Gea, Marika Rudler, and Manhal Izzy to gain expert insight into the selection, management, and outcomes of patients undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures.This EASL DeepDive webinar is supported by W. L. Gore & Associates. W. L. Gore & Associates has had no input into
EASL Studio Podcast: Endoscopic Management of Variceal Bleeding: Outdated or Evolving Beyond Tradition?
This EASL Studio episode discusses cutting-edge approaches for managing bleeding varices. Explore the evolution of endoscopic therapies, the role of interventional radiology, and decision-making for high-risk gastric varices. Gain insights into EUS-guided portal pressure assessment and its impact on tailoring treatment strategies.Moderator: Debbie ShawcrossFaculty: Wim Laleman, David PatchRelated
EASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin Deficiency
In this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency.Learning objectives:Learn more about the role of heterozygosity of alpha-1 as a risk factor for chronic liver disease, especially in the context of other causes such as MASLD or alcoholGet a better understandin
EASL DeepDive: Understanding and managing PBC symptoms
In this EASL DeepDive held on 03 July 2024, Palak Trivedi, Emma Culver, Andreas Kremer and Jessica Dyson explain the risk assessment in people with PBC as well as the mechanistic and treatment of fatigue and pruritus.Learning objectivesDiscover the latest mechanistic insights relating to the occurrence of PBC symptomsLearn more about the holistic management of PBC symptoms, with a particular empha
EASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?
In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient managem
EASL DeepDive: What is the future of PBC treatment?
In this EASL DeepDive held on 25 February 2025, Ana Lleo, Adriaan van der Meer, Gideon Hirschfield, and Bettina Hansen explore the future of primary biliary cholangitis (PBC) treatment. Discover the emerging therapies, current challenges and personalised approaches that are shaping the management of PBC.Learning objectivesLearn more about the molecular mechanisms underlying the disease and the po
EASL Studio Podcast: JHEP Live: JHEP at 40: What to Expect Next?
This episode celebrates 40 years of the Journal of Hepatology, EASL’s flagship journal.Tune in to discover how far we’ve come—and what’s next for the journal.Moderator: Thomas Berg Faculty: Paolo Angeli, Annalisa Berzigotti, Rajiv Jalan, Vlad Ratziu, Frank Tacke and Jessica Zucman-RossiAll EASL Studio Podcasts are available on EASL Campus.Click here to see all EASL Video Podcasts on Apple Podcasts
EASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big Questions
Rare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in the new EASL position paper. Join us to uncover how these advancements can address key hurdles in managing these rare malignancies.Read the position paper: Ra
EASL Studio Podcast: From Evidence to Action: Reducing Alcohol-Related Harm
This episode of EASL Studio explores insights from the European Alcohol Health Alliance Symposium, hosted by the WHO Regional Office for Europe in collaboration with EASL. Topics include managing alcohol marketing strategies, addressing gaps in cancer-related labelling, and understanding the influence of social norms on adolescent alcohol consumption. Learn from successful alcohol policy implement
EASL Studio Podcast: Understanding Sex Disparities in MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects men and women differently, yet sex-based differences remain poorly explored. In the week celebrating International Women’s Day, this EASL Studio episode debates the molecular, hormonal, and genetic mechanisms driving these disparities.Moderator: Saskia van MilFaculty: Sara Della Torre and Münevver DemirRelated episodeS4E9 YI
EASL Studio Podcast: Lessons from Your PET: Understanding and Evaluating Treatment for Wilson’s Disease
Tune into this EASL Studio episode to learn about the role of PET imaging in Wilson’s disease. Discover how PET advances understanding, supports treatment decisions, and enhances patient care in managing this rare liver disorder.Moderator: Debbie ShawcrossFaculty: Aftab Ala, Zoe Mariño and Thomas SandahlThis EASL Studio is supported by Orphalan and Univar Solutions.EASL has received no input from
EASL Studio Podcast: Liver Cancer Care in 2025: Progress, Hope, and What Lies Ahead
Join this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping the future and translating research into improved patient outcomes.Moderator: Thomas BergFaculty: Tim Greten and Anna SaborowskiThis EASL Studio is supported
EASL Studio Podcast: YI choice: From Idea to Abstract to Publication: Navigating Your Research journey
Watch this EASL Studio to start navigating your research journey with essential tips on generating ideas, refining hypotheses, and crafting standout abstracts for EASL Congress. Discover how to choose the right journal, prepare a submission-ready manuscript, and boost your career visibility in hepatology.Moderator: Thomas MarjotFaculty: Marta Afonso, Emma Andersson and Paolo AngeliRelated episodes
EASL Studio Podcast: JHEP Live – EASL CPGs on Hepatocellular Carcinoma: What’s New and How Will Practice Change?
Discover the latest updates from the updated EASL Clinical Practice Guidelines on Hepatocellular Carcinoma (HCC). This episode explores key advancements, their impact on clinical practice, and how they will shape the future of HCC diagnosis, treatment, and management. Join our faculty as they break down the changes and provide practical insights for healthcare professionals.Moderator: Thomas BergF
EASL Studio Podcast: 2025 Update on Steatotic Liver Disease: Rethinking Standard of Care
Join us for the season premiere of EASL Studio Season 8 as we unpack key insights from the Steatotic Liver Disease (SLD) Summit. Explore the evolving consensus on patient trajectories, advancements in ALD and MetALD treatment pathways, and the latest endpoint discussions. The episode also highlights a holistic approach to diagnosing and managing comorbidities and revisits the standard of care in l
EASL Studio Podcast: The liver as a master regulator of ageing, health, and longevity
This EASL Studio showcases cutting-edge research elucidating the role of the liver in ageing and exploring its role as a regulator of health and longevity. In particular, the liver’s function in modulating systemic ageing, its ability to buffer genetic and metabolic disturbances, and its influence on the progression of age-related diseases is discussed. Last but not least, panelists provides new i
EASL Studio Podcast: TIPS: How far can we go?
This EASL Studio episode examines the current relevance of Hepatic Encephalopathy (HE) and the roles of hepatologists and interventional radiologists in patient care. The discussion covers technical approaches, patient outcomes, and the expanding indications for TIPS.Tune in to:Learn about the critical roles of hepatologists and radiologists in managing HE.Understand technical factors, including T
EASL Studio Podcast: Sarcopenia: Converting research findings into clinical practice - Are we doing enough?
Sarcopenia, defined by a reduction in muscle mass and strength, significantly increases the risk of hospitalisation and mortality in patients with liver cirrhosis. This EASL Studio episode highlights the importance of incorporating sarcopenia assessment and management into routine clinical practice. Experts discuss the optimal timing for assessment and strategies for implementing effective interve
EASL Studio Podcast: Alcohol, cardiometabolic risks factors, and steatotic liver disease – From stigma to breakthrough therapies
This EASL Studio episode explores how alcohol worsens liver disease in patients with cardiometabolic risks, the stigma affecting diagnosis and care, and the latest therapeutic advances.Key topics of discussion include:Interaction between alcohol and cardiometabolic risksStigma and its impact on patient careIdentifying at-risk patients with clinical markersEmerging therapies and research opportunit
EASL Studio Podcast: What’s hot and not in liver transplantation: EASL CPG 2024 update
Join the experts as they explore the new updates to the liver transplantation clinical practice guidelines, and delve into the latest advancement and ongoing challenges faced in this field.Tune in to:Discover cutting-edge techniques like machine perfusion and extended criteria grafts.Learn about new transplant indications, including oncology and acute liver failure.Understand challenges in immunos
EASL Studio Podcast: Why does WHO engagement with Steatotic Liver Disease matter?
This episode is organised in collaboration with the Healthy Livers, Healthy Lives Coalition.FacultyJeffrey Lazarus (Moderator)Mazen Noureddin (Faculty)Shira Zelber-Sagi (Faculty)Kremlin Wickramasinghe (Faculty)The Healthy Livers, Healthy Lives Coalition’s activities are supported by Boehringer Ingelheim, Echosens, MSD, and Novo Nordisk.Our industry partners have had no input into the content of th
EASL Studio Podcast: Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?
This episode explores the latest developments in liver disease, with a focus on metabolic-associated steatotic liver disease (MASLD) and its impact on liver cancer, particularly hepatocellular carcinoma (HCC). The main focus is the emerging role of advanced imaging technologies. The discussion:Compares traditional ultrasound with advanced imaging techniques.Examines AI-based approaches in patient
EASL Studio Podcast: Are we relearning how to manage renal dysfunction in cirrhosis?
Renal dysfunction is a significant concern for patients with liver cirrhosis, affecting nearly 50% of those hospitalised and leading to various complications that can reduce survival rates. Recently, the diagnostic criteria for acute kidney injury (AKI) and hepatorenal syndrome (HRS) have been updated to better capture the diversity and incidence of these conditions in cirrhotic patients.This epis
EASL Studio Podcast: Arrivederci Milano, hallo Amsterdam!
Arrivederci Milano, hallo Amsterdam!FacultyAleksander Krag (Moderator)Debbie Shawcross (Moderator)Cyrielle Caussy (Faculty)Ana Lleo (Faculty)Francesco Negro (Faculty)Vlad Ratziu (Faculty)Virginia Hernández-Gea (Faculty)All EASL Studio Podcasts are available on EASL Campus.
EASL Studio Podcast: Education at the heart of EASL’s mission
EASL Studio - Education at the heart of EASL’s missionFacultySven Francque (Moderator)Krista Rombouts (Faculty)Rajeshwar Mookerjee (Faculty)Henning Grønbæk (Faculty)All EASL Studio Podcasts are available on EASL Campus.
EASL Studio Podcast: Landmark studies at the EASL Congress 2024
EASL Studio - Landmark studies at the EASL Congress 2024FacultyThomas Berg (Moderator)Rajiv Jalan (Faculty)Verena Keitel (Faculty)Frank Tacke (Faculty)All EASL Studio Podcasts are available on EASL Campus.
EASL Studio Podcast: SLD nomenclature: Need for refinement?
EASL Studio - SLD nomenclature: Need for refinement?FacultyAleksander Krag (Moderator)Meena Bansal (Faculty)Sven Francque (Faculty)Alexandre Louvet (Faculty)All EASL Studio Podcasts are available on EASL Campus.
EASL Studio Podcast: Exploring new frontiers: The AI liver taskforce initiative
EASL Studio - Exploring new frontiers: The AI liver taskforce initiativeFacultyEric Trépo (Moderator)Tom Lüdde (Faculty)Jakob Kather (Faculty)Raquel Pérez-López (Faculty)All EASL Studio Podcasts are available on EASL Campus.
EASL Studio Podcast: Advances in systemic treatments in liver cancer
EASL Studio - Advances in systemic treatments in liver cancerFacultyJosep Llovet (Moderator)Massimo Iavarone (Faculty)Matthias Pinter (Faculty)Jessica Zucman-Rossi (Faculty)All EASL Studio Podcasts are available on EASL Campus.
EASL Studio Podcast: Buongiorno Milano: What not to miss during EASL Congress
EASL Studio - Buongiorno Milano: What not to miss during EASL Congress.FacultyAleksander Krag (Moderator)Debbie Shawcross (Faculty)Thomas Berg (Faculty)Ahmed Elsharkawy (Faculty)All EASL Studio Podcasts are available on EASL Campus.
EASL Studio Podcast: What‘s hot in viral hepatitis in 2024?
This session covers a wide range of topics relevant to the current landscape of viral hepatitis, including elimination efforts, resistance to direct-acting antivirals (DAAs), surveillance methods during and after therapy. This talk provides you with valuable insights through an up-to-date overview of the latest developments and challenges in the field.FacultyThomas Berg (Moderator)Jordan Feld (Fac
EASL Studio Podcast: Endohepatology: The endoscopic liver gold rush
This insightful discussion is centred on the burgeoning field of endohepatology, where advanced endoscopic techniques revolutionise hepatology practice. With this episode, explore the broad scope of endoscopic procedures (including EUS-guided liver biopsy, portal pressure measurement, and gastric varices embolisation) and their transformative impact on diagnostics and therapeutic interventions in
EASL Studio Podcast: Resmetirom: First approved drug for MASH, for whom and for how long?
This episode explores the approval of resmetirom for NASH, analysing its integration into clinical practice and patient eligibility. The experts also discuss the role of lifestyle interventions alongside resmetirom, the use of biomarkers for patient selection, treatment monitoring, and the expected landscape changes over the next five years.FacultyAleksander Krag (Moderator)Naim Alkhouri (Faculty)
EASL Studio Podcast: Do we care enough about the importance of DILI/DHILI ?
Join us for a critical discussion on the significance of Drug and Herbal & Dietary Supplement-Induced Liver Injury (DHILI). In this episode, the speakers explore the importance of DHILI, assess recent advancements, and deliberate on the obstacles hindering further progress in addressing this pressing healthcare concern.This episode is organised in collaboration with the EASL DHILI Consortium.F
EASL Studio Podcast: Assessment of clinically significant portal hypertension in 2024 – Is it time to say goodbye to invasive measurements?
In this episode, experts explore the shift away from invasive measurements in assessing clinically significant portal hypertension. The speakers address the crucial data needed to enhance the reliability and applicability of these non-invasive methods and introduce several advanced elastography techniques, shaping the future of portal hypertension assessment.FacultyBogdan Procopet (Moderator)Maria
EASL Studio Podcast: YI Choice: Citizen science: Societal engagement in hepatology
This episode aims at highlighting the importance of patient and public involvement in research. More precisely, the speakers focus on the importance of involving patients in research, practical steps to involve patients in research, and insights from EASL including engagement of patients in the EASL-Lancet Commission.FacultyMarta Alonso-Peña (Moderator)Kate Jack (Faculty)Marko Korenjak (Faculty)Th
